Latest Harvard Medical School in Boston Stories
A substantial percentage of patients who receive radiologist recommendations for chest computed tomography (CT) to evaluate abnormal findings on outpatient chest X-rays have clinically relevant
CHICAGO — Visceral, or deep belly, obesity is a risk factor for bone loss and decreased bone strength in men, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). "It is important for men to be aware that excess belly fat is not only a risk factor for heart disease and diabetes, it is also a risk factor for bone loss," said Miriam Bredella, M.D., radiologist at Massachusetts General Hospital and associate professor of...
New research announced on Monday offers evidence that drinking coffee is associated with a decreased risk of a common and slow-growing type of skin cancer known as basal cell carcinoma.
The Autism Consortium, an innovative Boston area collaboration of researchers, clinicians, funders and families dedicated to catalyzing research and enhancing clinical care for autism spectrum disorders (ASDs), announced that it will begin a new initiative on Translational Medicine and Autism Therapeutics.
The Autism Consortium, an innovative collaboration of researchers, clinicians, funders and families dedicated to catalyzing research and enhancing clinical care for autism spectrum disorders (ASDs), held its fourth annual symposium on October 28th, 2009, at Harvard Medical School in Boston.
Overweight and obese people may face more struggles with losing weight during tough economic times.
Women who took beta carotene or vitamin C or E or a combination of the supplements had a similar risk of cancer as women who did not take the supplements.
It was announced on Tuesday that there is no evidence that brand-name drugs given to care for heart and other cardiovascular situations work any more effectively than their less expensive generic equivalents.
TheraGenetics Limited, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system (CNS) disorders, announced today that Richard Kivel, Chief Executive Officer of TheraGenetics will present at the 2008 Boston Biotech R&D Conference, at 1:00 p.m.
Researchers claim they developed a safer way to make powerful stem cells from ordinary skin cells, improving research focused on so-called regenerative medicine.
- Growing in low tufty patches.